Literature DB >> 10673165

Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease.

P M Calverley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673165     DOI: 10.1164/ajrccm.161.2.16125_1

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  20 in total

Review 1.  Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options.

Authors:  M Friedman; D E Hilleman
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease.

Authors:  J van der Palen; E Monninkhof; P van der Valk; S D Sullivan; D L Veenstra
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

3.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

4.  Knowledge and attitudes of family physicians coming to COPD continuing medical education.

Authors:  Barbara P Yawn; Peter C Wollan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 5.  Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Therapy for chronic obstructive pulmonary disease in the 21st century.

Authors:  Louise E Donnelly; Duncan F Rogers
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Theophylline and dexamethasone in combination reduce inflammation and prevent the decrease in HDAC2 expression seen in monocytes exposed to cigarette smoke extract.

Authors:  Xue-Jiao Sun; Zhan-Hua Li; Yang Zhang; Xiao-Ning Zhong; Zhi-Yi He; Ji-Hong Zhou; Si-Ning Chen; Yuan Feng
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

Review 8.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

9.  Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study.

Authors:  Niels H Chavannes; Tjard R J Schermer; Emiel F M Wouters; Reinier P Akkermans; Richard P N Dekhuijzen; Jean W M Muris; Chris van Weel; Onno C P van Schayck
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29

Review 10.  Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler.

Authors:  Richard Hodder; David Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.